These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 21245640)
21. Marinesco-Sjögren syndrome caused by a new SIL1 frameshift mutation. Cerami C; Tarantino P; Cupidi C; Annesi G; Lo Re V; Gagliardi M; Piccoli T; Quattrone A J Neurol Sci; 2015 Jul; 354(1-2):112-3. PubMed ID: 25982182 [No Abstract] [Full Text] [Related]
22. Muscle pathology in Marinesco-Sjogren syndrome: a unique ultrastructural feature. Sasaki K; Suga K; Tsugawa S; Sakuma K; Tachi N; Chiba S; Imamura S Brain Dev; 1996; 18(1):64-7. PubMed ID: 8907346 [TBL] [Abstract][Full Text] [Related]
23. Targeting the enhanced ER stress response in Marinesco-Sjögren syndrome. Kashimada A; Hasegawa S; Isagai T; Uchiyama T; Matsuo M; Kawai M; Goto M; Morio T; Hayashi YK; Takagi M J Neurol Sci; 2018 Feb; 385():49-56. PubMed ID: 29406913 [TBL] [Abstract][Full Text] [Related]
24. Neuro-otological findings in a case of Marinesco-Sjögren syndrome with nystagmus. Yoshimoto Y Auris Nasus Larynx; 1987; 14(3):171-6. PubMed ID: 3482781 [TBL] [Abstract][Full Text] [Related]
25. Congenital cataract, ataxia, external ophthalmoplegia and dysphagia in two siblings. A Marinesco-Sjögren-like syndrome. Schulz S; Vielhaber S; Muschke P; Mohnike K; Gooding R; Wieacker P Neuropediatrics; 2007 Apr; 38(2):88-90. PubMed ID: 17712737 [TBL] [Abstract][Full Text] [Related]
26. [Marinesco-Sjögren syndrome with chronic progressive ophthalmoplegia caused by presumed defective oxidative phosphorylation]. Berio A; Piazzi A Pediatr Med Chir; 1996; 18(1):99-103. PubMed ID: 8685033 [TBL] [Abstract][Full Text] [Related]
30. Novel SIL1 nonstop mutation in a Chinese consanguineous family with Marinesco-Sjögren syndrome and Dandy-Walker syndrome. Gai N; Jiang C; Zou YY; Zheng Y; Liang DS; Wu LQ Clin Chim Acta; 2016 Jul; 458():1-4. PubMed ID: 27106665 [TBL] [Abstract][Full Text] [Related]
31. MR imaging features in Marinesco-Sjögren syndrome: severe cerebellar atrophy is not an obligatory finding. Reinhold A; Scheer I; Lehmann R; Neumann LM; Michael T; Varon R; Von Moers A AJNR Am J Neuroradiol; 2003 May; 24(5):825-8. PubMed ID: 12748078 [TBL] [Abstract][Full Text] [Related]
32. Response of serum carboxylated and undercarboxylated osteocalcin to risedronate monotherapy and combined therapy with vitamin K(2) in corticosteroid-treated patients: a pilot study. Hozuki T; Imai T; Tsuda E; Matsumura A; Yamamoto D; Toyoshima T; Suzuki S; Yamauchi R; Hayashi T; Hisahara S; Shimohama S Intern Med; 2010; 49(5):371-6. PubMed ID: 20190467 [TBL] [Abstract][Full Text] [Related]
33. Other autosomal recessive and childhood ataxias. De Michele G; Filla A Handb Clin Neurol; 2012; 103():343-57. PubMed ID: 21827899 [TBL] [Abstract][Full Text] [Related]
34. PERK inhibition delays neurodegeneration and improves motor function in a mouse model of Marinesco-Sjögren syndrome. Grande V; Ornaghi F; Comerio L; Restelli E; Masone A; Corbelli A; Tolomeo D; Capone V; Axten JM; Laping NJ; Fiordaliso F; Sallese M; Chiesa R Hum Mol Genet; 2018 Jul; 27(14):2477-2489. PubMed ID: 29718201 [TBL] [Abstract][Full Text] [Related]
36. Risedronate and ergocalciferol prevent hip fracture in elderly men with Parkinson disease. Sato Y; Honda Y; Iwamoto J Neurology; 2007 Mar; 68(12):911-5. PubMed ID: 17372126 [TBL] [Abstract][Full Text] [Related]
37. Marinesco-Sjögren syndrome due to SIL1 mutations with a comment on the clinical phenotype. Horvers M; Anttonen AK; Lehesjoki AE; Morava E; Wortmann S; Vermeer S; van de Warrenburg BP; Willemsen MA Eur J Paediatr Neurol; 2013 Mar; 17(2):199-203. PubMed ID: 23062754 [TBL] [Abstract][Full Text] [Related]
38. Cerebrotendinous xanthomatosis without tendon xanthomas mimicking Marinesco-Sjoegren syndrome: a case report. Siebner HR; Berndt S; Conrad B J Neurol Neurosurg Psychiatry; 1996 May; 60(5):582-5. PubMed ID: 8778269 [TBL] [Abstract][Full Text] [Related]
39. Phenotype-genotype correlations in patients with Marinesco-Sjögren syndrome. Ezgu F; Krejci P; Li S; de Sousa C; Graham JM; Hansmann I; He W; Porpora K; Wand D; Wertelecki W; Schneider A; Wilcox WR Clin Genet; 2014 Jul; 86(1):74-84. PubMed ID: 23829326 [TBL] [Abstract][Full Text] [Related]
40. Efficacy of risedronate in Japanese male patients with primary osteoporosis. Majima T; Shimatsu A; Komatsu Y; Satoh N; Fukao A; Ninomiya K; Matsumura T; Nakao K Intern Med; 2008; 47(8):717-23. PubMed ID: 18421187 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]